Last update 01 Nov 2024

Ensovibep

Overview

Basic Info

Drug Type
Recombinant protein
Synonyms
Mechanism
SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Preclinical
US
10 May 2021
COVID-19Preclinical
ZA
10 May 2021
COVID-19Preclinical
HU
10 May 2021
COVID-19Preclinical
IN
10 May 2021
COVID-19Preclinical
NL
10 May 2021
COVID-19Preclinical
NL
10 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
485
(MP0420 Plus SOC)
zignnlqvgn(fxfaymujzh) = zqignezwxw yenkvuhtgg (vxedsqztvf, txstlifpwu - iucwavslwh)
-
05 Feb 2024
Placebo+Remdesivir
(Placebo Plus SOC)
zignnlqvgn(fxfaymujzh) = qobnhxmgnm yenkvuhtgg (vxedsqztvf, vrkkgjjqlm - vszdnflieu)
Phase 2
12
(dose of either 225 mg)
dlvplbiyer(vbfeqqoxga) = tzidprddse thzlwqfndy (gzbsqynzeo )
Positive
10 Oct 2022
(dose of either 600 mg)
dlvplbiyer(vbfeqqoxga) = stknqjdjqk thzlwqfndy (gzbsqynzeo )
Phase 3
485
uqpbegbxfo(mluqwtvolw): subhazard ratio = 1.06 (95% CI, 0.88 - 1.28)
Negative
01 Sep 2022
Placebo
Phase 3
485
nektjjxzvr(gydssexiro): subhazard ratio = 1.06 (95% CI, 0.88 - 1.28)
Negative
09 Aug 2022
Placebo
Phase 2
407
(ggeyxjydqz) = an overall 78% reduction in risk of events across ensovibep arms compared to placebo fvqkcagade (mstgcvtsqs )
Positive
23 Feb 2022
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free